Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
News about Option Care Health, Inc. (OPCH) centers on its role as the nation’s largest independent provider of home and alternate site infusion services and on its regular financial and corporate updates. The company issues detailed quarterly earnings releases, often accompanied by Form 8-K filings, that cover net revenue, net income, earnings per share, and non-GAAP metrics such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS.
Investors following OPCH news will see announcements of preliminary and final quarterly and full-year financial results, as well as updated financial guidance ranges for net revenue, Adjusted EBITDA and Adjusted diluted earnings per share. These releases typically include management commentary on performance, cash flow from operations, stock repurchase activity and capital structure developments.
Option Care Health also uses news releases to communicate capital allocation decisions, such as expansions of its share repurchase program authorization, and to describe amendments to its credit agreements that affect term loans and revolving credit facilities. SEC Form 8-K filings referenced in the news provide additional detail on these material definitive agreements and financial obligations.
Corporate governance and leadership changes are another recurring news theme. For example, the company has announced a Chief Financial Officer transition, outlining the incoming CFO’s background, compensation arrangements and the outgoing CFO’s advisory role. News items also highlight Option Care Health’s participation in major healthcare and finance conferences, including events hosted by J.P. Morgan, UBS, Jefferies, Deutsche Bank and Bank of America, with webcasts and presentation materials made available to investors.
In addition, Option Care Health appears in partner company releases, such as Quince Therapeutics’ announcements of a strategic relationship for specialty infusion therapy support. These items describe how Option Care Health’s national network of specialty pharmacies and ambulatory infusion suites may be used to administer specific infused therapies, particularly in rare disease indications. For ongoing coverage of these financial, strategic and operational developments, OPCH news on this page aggregates company press releases, partner announcements and related disclosures.
Option Care Health announced a public offering of 18 million shares at $20.25 each, increasing from the original 15 million shares. This represents approximately 10% of total shares outstanding, and the underwriters have a 30-day option for an additional 2.7 million shares. Following the offering, the Selling Stockholder's ownership will drop from 37.7% to 27.7%. The offering is scheduled to close on August 5, 2021. Option Care Health will not receive any proceeds from this sale.
Option Care Health has announced a public offering of 15 million shares of common stock by an affiliate of Madison Dearborn Partners, with an additional option for underwriters to purchase 2.25 million more shares. This represents approximately 8.3% of outstanding shares, reducing the Selling Stockholder's interest from 37.7% to 29.3%. The offering proceeds will benefit equity holders of the Selling Stockholder, including Walgreens, which will maintain a 21% indirect financial interest post-offering. Goldman Sachs is the sole underwriter for this transaction.
Option Care Health, the largest independent provider of home and alternate site infusion services, reported strong financial results for Q2 2021. Net revenue reached $860.3 million, a 16.1% increase year-over-year. Gross profit rose to $199.0 million, equating to 23.1% of net revenue, with net income of $31.8 million or $0.18 per share, marking a turnaround from a net loss in Q2 2020. Adjusted EBITDA grew by 33.3% to $72.8 million, and cash flow from operations improved to $73.7 million. The company also completed an acquisition of BioCure's assets for $18.9 million.
Option Care Health (Nasdaq: OPCH) has appointed Dr. Seema Kumbhat as its new Chief Medical Officer. In her role, she will oversee clinical strategies, operations, quality improvement, and regulatory compliance. Dr. Kumbhat has a strong background, previously serving as Senior Vice President and Regional Medical Officer at Fresenius Kabi, and has held positions at major healthcare organizations. CEO John Rademacher expressed confidence in her ability to enhance patient care and clinical outcomes as the company continues to differentiate its infusion services.
On July 21, 2021, AlayaCare and Option Care Health (Nasdaq: OPCH) announced a technology collaboration to enhance software for alternate site infusion therapy. This partnership aims to improve patient engagement and care delivery through advanced automation and data capture tools. Option Care Health currently utilizes AlayaCare's software to manage clinical resources. Both companies are focused on enhancing patient experiences and achieving superior clinical outcomes through this strategic collaboration.
Option Care Health (NASDAQ: OPCH) announced it will release its second quarter results for the period ending June 30, 2021, on August 3, 2021, prior to the market opening. The management team will conduct a conference call at 8:30 a.m. E.T. on the same day to discuss the results. The call will be accessible via phone or live audio webcast, with a replay available shortly after for approximately 90 days. Option Care Health is the largest independent provider of home and alternate site infusion services in the United States, employing over 5,000 individuals.
Option Care Health announced an underwritten public offering of 15,000,000 shares at $20.00 per share, increasing from an initial 10,000,000 shares. The offering, led by Goldman Sachs & Co. LLC, is expected to close on June 10, 2021, subject to customary conditions. The Selling Stockholder will reduce its ownership from 47.3% to 38.9% post-offering (or 37.7% if the underwriter's option is exercised). The company will not receive proceeds from this offering.
Option Care Health (NASDAQ: OPCH) announced the sale of 10,000,000 shares of its common stock by an affiliate of Madison Dearborn Partners, representing approximately 5.6% of current outstanding shares. The underwriter, Goldman Sachs & Co. LLC, has a 30-day option to purchase an additional 1,500,000 shares. After this offering, the selling stockholder's interest will decrease from 47.3% to 41.7% (or 40.9% with the additional shares). The company will not receive any proceeds from the offering.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced that CEO John C. Rademacher and CFO Mike Shapiro will participate in two major investor conferences. They will present at the William Blair 41st Annual Growth Stock Conference on June 2, 2021, at 3:00 p.m. ET, and the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021, at 1:20 p.m. ET. Webcast links for both events will be available on their investor relations website.
Option Care Health (Nasdaq: OPCH) reported strong financial results for Q1 2021, with net revenue of $759.2 million, an increase of 7.6% from the previous year. Gross profit rose to $165.5 million, representing 21.8% of net revenue. The net loss narrowed to $2.9 million, or $0.02 per share, improving from a loss of $19.9 million in Q1 2020. Adjusted EBITDA surged 30% to $52.2 million. The company also announced the retirement of its second lien debt and an acquisition of chronic therapy assets for $18.5 million.